Investigating COVID-19 response in infants

(c) David Pratt

Research led by Dr Anu Goenka has shown how babies are protected from severe COVID-19 infections.

As a Clinical Lecturer in Paediatric Infectious Diseases and Immunology, much of my clinical and research work is carried out in the Bristol Royal Hospital for Children. When the COVID-19 pandemic hit, we weren’t sure how the disease would impact the young children and infants in our care.

Babies are very vulnerable to other respiratory viruses, such as the flu and RSV (respiratory syncytial virus), so initially we thought that they may also be susceptible to severe COVID-19. It soon became apparent, however, that the four babies at our hospital who had tested positive for coronavirus were only mildly affected by the disease, with all of them recovering after just a few days. (more…)

Supporting scientific discoveries

(c) David Pratt

Philanthropic support has allowed PhD student Amy Holt to explore how aspirin could improve bowel cancer treatments.

I’ve always found cell biology fascinating: the way that cells work, how they build us as human beings and how they can cause disease. It’s what drew me to studying cancer. By learning about what goes wrong in cancer cells, we also learn a lot about normal cells and how they should function.

Bowel cancer has one of the highest mortality rates of any cancer, because it’s often detected at quite a late stage. Researchers have established that taking aspirin for long periods of time decreases your risk of developing bowel cancer. But what we don’t know is exactly why that is. Throughout my PhD, my research group and I have been exploring how aspirin influences cellular functions to make cells less likely to become cancerous and to slow the progression of a cancer. (more…)

Dr Imke Sittel (PhD 2017): tackling climate change through plant power 

In 2019, co-founders Dr Imke Sittel (PhD 2017) and Dr David Benito-Alifonso set up Glaia – an environmentally conscious startup which is on a mission to reduce the carbon footprint of agricultural food production. The revolutionary technology behind Glaia, which Imke and David developed at the University of Bristol, uses nanomaterial-based solutions to allow plants to harvest light more efficiently. By increasing crop yields and lowering emissions, this forward-thinking startup could play a pivotal role in tackling climate change and ensuring food security in future years.

We spoke to Dr Imke Sittel to find out more about startup life and to hear her fond memories of her time at the University.

(more…)

A Bristol life: Dr John Reeks (MA 2010, PhD 2015)

For over 12 years Dr John Reeks has been a part of the University of Bristol: first as an MA student, then as a PhD researcher and now as a lecturer in the Department of History. Here he tells us more about what makes the University such a special place for him.

(more…)

Owning our Digital Destinies – a look at the University’s Bristol Digital Futures Institute

Image (C) Shutterstock

Researchers, businesses, government and diverse communities must come together to proactively shape our digital future, say Professors Susan Halford and Dimitra Simeonidou, Co-Directors of the University’s Bristol Digital Futures Institute (BDFI).

The BDFI is led by Professor Susan Halford (School of Sociology, Politics and International Studies) and Professor Dimitra Simeonidou (Department of Electrical and Electronic Engineering). For the past decade Professor Halford’s work has focused on the interface between social and computational sciences, while Professor Simeonidou specialises in high-performance networks and future internet research. This complementary expertise feeds into the BDFI, which aims to transform the way we create, utilise and evaluate new digital technologies to benefit our society now and in the future. (more…)

Spotlight on COVID-19 research: Professors Imre Berger and Christiane Schaffitzel

COVID-19: Discovery of a druggable pocket in the SARS-CoV-2 spike protein

When husband-and-wife dynamic duo Professors Imre Berger (Max Planck-Bristol Centre for Minimal Biology) and Christiane Schaffitzel (School of Biochemistry) found themselves in lockdown in March 2020, unable to teach or run their normal workday at the University of Bristol, they did not hang up their lab coats. Instead (while complying with all necessary safety measures) they assembled a cohort of volunteers from their teams and set to work to do what they could to stop COVID-19 in its tracks, as part of the bigger Bristol University COVID-19 Emergency Research Group (UNCOVER). (more…)

Spotlight on COVID-19 research: Professor Jonathan P Reid

 

Image of aerosol research (C) Declan Costello

COVID-19: Looking at different ways in which aerosol research can support the fight against COVID-19

As Director of the EPSRC Centre for Doctoral Training in Aerosol Science and the Bristol Aerosol Research Centre, Professor Jonathan Reid’s approach to tackling COVID-19 is, naturally, focused on aerosols. ‘Aerosols’ is a term that is used to refer to a collection of particles that are airborne and with sizes typically smaller than the diameter of a human hair. When we speak, breathe, cough or even sing, we generate hundreds of these particles that someone else could breathe in, transmitting the virus responsible for COVID-19.

A key piece of work from Professor Reid has shown that there is significantly less risk of COVID-19 transmission from anaesthesia procedures than was previously thought. This is an important finding at a time when many operations and NHS procedures have been postponed or cancelled, causing problems for patients in the UK.

Since the outset of the COVID-19 pandemic, there has been much debate about the danger to hospital staff from anaesthetic procedures. Concerns include that inserting a tube in the patient’s airway (intubation) before surgery or removing it at the end (extubation) may produce a fine mist of small aerosol particles and spread the COVID-19 virus to nearby staff.

(more…)

Spotlight on COVID-19 Research: Dr Laura Rivino

COVID-19: Immune correlates of hyperinflammation and protective immunity in COVID-19

As we grapple with the nightmare scenario of a global pandemic, scientists around the world, including at Bristol, are diving into research around as many aspects of the COVID-19 virus as possible. One of the key findings to date is that in serious cases the body’s immune system goes into ‘overdrive’. Evidence accumulated so far suggests that the life-threatening COVID-19 complications are related to immune dysregulation, arising because of viral infection in the form of a hyperinflammatory syndrome accompanied by increased plasma levels of pro-inflammatory cytokines.(1-2)

Immunologist Dr Laura Rivino is conducting a pilot study that should provide us with a clearer understanding of the immune response underlying both the immunopathology and immune protection in patients with COVID-19. Her team’s hypothesis is that it would be beneficial to use a combination of strategies where the anti-inflammatory response can be blocked while simultaneously boosting the anti-viral immune response, with an expectation of ensuring viral clearance and establishment of immunological memory.

(more…)

Spotlight on COVID-19 Research: Dr Saffron Karlsen

COVID-19: Black lives in lockdown – the pandemic experiences of people with Black, Asian and minority ethnicities living in the South West

For many people, the reports that COVID-19 was disproportionately affecting those in Black, Asian and minority ethnic communities was news to them. For Dr Saffron Karlsen, however, it was not. As Associate Professor in Sociology and a specialist in inequalities in health research, Dr Karlsen has spent over 20 years looking at how structural and societal  inequalities hamper health and healthcare for those in ethnic minority groups. (more…)